Literature DB >> 21696421

S100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS.

N A Renner1, R K Redmann, T Moroney-Rasmussen, H A Sansing, P P Aye, P J Didier, A A Lackner, A G Maclean.   

Abstract

AIMS: The pathogenesis of human/simian immunodeficiency virus encephalitis (HIVE/SIVE) remains incompletely understood, but is associated with alterations in the blood-brain barrier. At present, it is not possible to easily determine if an individual has HIVE/SIVE before post mortem examination.
METHODS: We have examined serum levels of the astroglial protein S100β in SIV-infected macaques and show that it can be used to determine which animals have SIVE. We also checked for correlations with inflammatory markers such as CCL2/MCP-1, IL-6 and C-reactive protein.
RESULTS: We found that increased S100β protein in serum correlated with decreased expression of the tight junction protein zonula occludens-1 on brain microvessels. Furthermore, the decrease in zonula occludens-1 expression was spatially related to SIVE lesions and perivascular deposition of plasma fibrinogen. There was no correlation between encephalitis and plasma levels of IL-6, MCP-1/CCL2 or C-reactive protein.
CONCLUSIONS: Together, these data indicate that SIVE lesions are associated with vascular leakage that can be determined by S100β protein in the periphery. The ability to simply monitor the presence of SIVE will greatly facilitate studies of the neuropathogenesis of AIDS.
© 2011 The Authors. Neuropathology and Applied Neurobiology © 2011 British Neuropathological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21696421      PMCID: PMC3234337          DOI: 10.1111/j.1365-2990.2011.01200.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  54 in total

1.  Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex.

Authors:  L A Pemberton; B J Brew
Journal:  J Clin Virol       Date:  2001-10       Impact factor: 3.168

Review 2.  Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism.

Authors:  Pasquale Annunziata
Journal:  J Neurol       Date:  2003-08       Impact factor: 4.849

3.  Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.

Authors:  M C Zink; G D Coleman; J L Mankowski; R J Adams; P M Tarwater; K Fox; J E Clements
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

4.  Serum S-100beta as a possible marker of blood-brain barrier disruption.

Authors:  M Kapural; Lj Krizanac-Bengez; G Barnett; J Perl; T Masaryk; D Apollo; P Rasmussen; M R Mayberg; D Janigro
Journal:  Brain Res       Date:  2002-06-14       Impact factor: 3.252

5.  HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.

Authors:  Ibolya E András; Hong Pu; Mária A Deli; Avindra Nath; Bernhard Hennig; Michal Toborek
Journal:  J Neurosci Res       Date:  2003-10-15       Impact factor: 4.164

6.  Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection.

Authors:  G Trillo-Pazos; A Diamanturos; L Rislove; T Menza; W Chao; P Belem; S Sadiq; S Morgello; L Sharer; D J Volsky
Journal:  Brain Pathol       Date:  2003-04       Impact factor: 6.508

7.  Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.

Authors:  Andrew A Kanner; Nicola Marchi; Vincent Fazio; Marc R Mayberg; Michael T Koltz; Vitaly Siomin; Glen H J Stevens; Thomas Masaryk; Barbara Aumayr; Barbara Ayumar; Michael A Vogelbaum; Gene H Barnett; Damir Janigro
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

8.  Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples.

Authors:  Elena V Ryzhova; Peter Crino; Linda Shawver; Susan V Westmoreland; Andrew A Lackner; Francisco González-Scarano
Journal:  Virology       Date:  2002-05-25       Impact factor: 3.616

9.  Peripheral markers of brain damage and blood-brain barrier dysfunction.

Authors:  Nicola Marchi; Peter Rasmussen; Miranda Kapural; Vince Fazio; Kelly Kight; Marc R Mayberg; Andrew Kanner; Barbara Ayumar; Ben Albensi; Marco Cavaglia; Damir Janigro
Journal:  Restor Neurol Neurosci       Date:  2003       Impact factor: 2.406

10.  Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients.

Authors:  Tilmann O Kleine; Ludwig Benes; Peter Zöfel
Journal:  Brain Res Bull       Date:  2003-08-15       Impact factor: 4.077

View more
  5 in total

1.  Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion.

Authors:  Nicole A Renner; Hope A Sansing; Lisa A Morici; Fiona M Inglis; Andrew A Lackner; Andrew G MacLean
Journal:  J Neurovirol       Date:  2012-04-26       Impact factor: 2.643

2.  The flavivirus dengue induces hypertrophy of white matter astrocytes.

Authors:  Kim M Lee; Kevin B Chiu; Hope A Sansing; Peter J Didier; Andrew A Lackner; Andrew G MacLean
Journal:  J Neurovirol       Date:  2016-06-06       Impact factor: 2.643

3.  An inverted blood-brain barrier model that permits interactions between glia and inflammatory stimuli.

Authors:  Hope A Sansing; Nicole A Renner; Andrew G MacLean
Journal:  J Neurosci Methods       Date:  2012-04-06       Impact factor: 2.390

4.  Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques.

Authors:  Kim M Lee; Kevin B Chiu; Peter J Didier; Kate C Baker; Andrew G MacLean
Journal:  Brain Behav Immun       Date:  2015-07-17       Impact factor: 7.217

5.  Form follows function: astrocyte morphology and immune dysfunction in SIV neuroAIDS.

Authors:  Kim M Lee; Kevin B Chiu; Nicole A Renner; Hope A Sansing; Peter J Didier; Andrew G MacLean
Journal:  J Neurovirol       Date:  2014-06-27       Impact factor: 2.643

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.